FY2020 results Recovery dynamic engaged in H2, strong ambtitions for the next years - 17 March 2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
SUMMARY 1. 2020 ACTIVITY : NUMEROUS COMMERCIAL SUCCESSES IN A CHALLENGING ENVIRONEMENT 2. FINANCIAL RESULTS: RECOVERY ENGAGED IN H2 3. OUTLOOK : STRONG GROWTH IN 2021 & FOR THE NEXT YEARS 4. APPENDIX 2
STRATEGIC POSITION: OFFER TURNKEY SOLUTIONS FOR INDUSTRIAL 3D PRINTING Expertise on the whole value chain of 3D printing SYSTEMS PRODUCTS PRINTERS, MATERIALS, SOFTWARE MANUFACTURING OF PARTS ON DEMAND AND MEDICAL APPLICATIONS 3D PRINTERS & RAPID LIQUID RESINS & 3D MODELING DESIGN & ON-DEMAND AUDIOLOGY, 4 CHIROPODY AND DENTAL ADDITIVE FORGING POLYMER POWDERS SOFTWARES MANUFACTURING 4
COMMERCIAL SUCCESSES DESPITE A CHALLENGING ENVIRONMENT Major contracts for liquid resins in More sales of Laser Sintering Good commercial dynamic on other fronts Medical 3D Printers • Partnership with 2 European specialist & a large • Q1 2020 : 6 SLS printers sold to three chemical • Jewelry applications : 2 clients installing a dozen of wax machines global player for dental materials industry players each • Several printers LD10 & LD20 installed as well • Dozens of tons of resins to be consumed once their • Q4 2020 : New contracts with 2 companies in the • 3D modeling softwares : largest contract in history in the truck production is stabilized steel industry & food packaging industry industry covering a transformation program for 50 design engineers 5
CONSOLIDATE STRATEGIC POSITIONS WITH NEW INNOVATIVE SOLUTIONS FOR CLIENTS Implementing new innovative solutions for Software and Printers… …to strengthen Prodways strategic position Integrate Cloud solutions for 3D Modeling • Integrating 3DEXPERIENCE® platform of Dassault Systèmes Reinforced Software expertise Prodways is now one of the few industrial 3D printer manufacturers • Offer launched in Europe & United States1 worldwide to offer this 3D software expertise Improving the precision & efficiency of MovingLight printers for aligners applications • Super-Resolution 3D: new algorithm to reach
OPERATIONAL TRANSFORMATION TO IMPROVE PROFITABILITY & PRODUCTION CAPACITY Final phase of group synergies plan fast-tracked Increased production capacity Transformation launched in Q4 to continue in 2021 of Materials for dental applications Adapt the fabrication of printers to the ramp-up of the activity and location of the key clients Upgrading the production capacity to match strong commercial perspectives Transferring the production of the historical workshop in Paris region to the existing sites in Annecy and in the US More operational synergies by regrouping sites & teams +50% increase in 8 months to reach 100 tons/year Optimizing fixed cost structure 7
FINANCIAL RESULTS : RECOVERY ENGAGED IN H2 Var. Var. (in €million) H1 2019 H2 2019 FY2019 H1 2020 H2 2020 FY2020 H2 2020 FY2020 vs H2 2019 vs FY2019 Revenue 35,3 36,0 71,3 26,8 30,4 57,2 -5,6 -14,1 Reduced impact in H2 compared to H1 EBITDA1 2,6 2,7 5,3 1,4 1,9 3,3 -0,8 -2,0 Positive EBITDA despite impact on revenues EBIT2 -1,0 -0,5 -1,5 -2,9 -0,9 -3,8 -0,4 -2,3 Limited decrease of Operating income Operating income -2,4 -1,3 -3,8 -10,0 -4,8 -14,8 -3,5 -11,0 Financial result -0,1 -0,2 -0,3 -0,2 -0,1 -0,3 +0,1 -0,0 Net income group share -2,8 -1,4 -4,2 -8,7 -5,3 -13,9 -3,8 -9,7 (1) Operating income before "Net depreciation, amortization and provisions", "Other items of operating income" and “Share in the results of associated companies”. (2) “Operating income before "Other items of operating income" and “Share in the results of associated companies”. 9
SYSTEMS DIVISION: TOP LINE IMPACTED BY MACRO SITUATION BUT RESILIENT EBITDA Revenues impacted by wait & see Limited EBITDA1 decrease (€m) environnement -€4,4 m 23,6 8.6% 8.0% margin margin 19,2 -€0,5 m 2,0 1,5 H2 19 H2 H2 20 H2 19 H2 20 • Implementation of cost saving initiatives and benefit from • Strong hit of Covid-19 but month by month improvement governments support measures • Good performance of Materials activity 10 (1) Operating income before "Net depreciation, amortization and provisions", "Other items of operating income" and “Share in the results of associated companies”.
PRODUCTS DIVISION: LIMITED DECREASE DESPITE SECOND LOCKDOWN Revenue (€m) EBITDA1 (€m) -€1.5 m 12,8 11,3 10.7% 10.3% margin margin -€0.2 m 1,4 1,2 H2 2019 H2 H2 2020 H2 2019 H2H2 2020 • Lower impact of the 2nd lockdown compared to the 1st one • EBITDA margin maintained above 10% • Recovery engaged with medical activities almost back to • Benefit from government support measures 2019 level in Q4 11 (1) Operating income before "Net depreciation, amortization and provisions", "Other items of operating income" and “Share in the results of associated companies”.
SOUND BALANCE SHEET AT END-2020 In € million Positive net cash position after a challenging year while continuing investments 1 1 AVAILABLE CASH OF €22.5M AS OF END 2020 12 1 Before IFRS16 leases debt and including treasury shares
OUTLOOK : STRONG GROWTH IN 2021 & FOR THE NEXT YEARS 13
A GROWING MARKET FOR 3D PRINTING THROUGH SCALING OF APPLICATIONS Prodways track record proves its capacity to capture market growth by scaling new applications to industrial production ~€100 bn global market projected in 20291 vs ~€10 bn in 2021 Dental: Chiropody: Jewellery: Positive trends supporting a strong valuation of 3D printing companies in the US 1 million aligners 50,000 insoles 250,000 jewels / year / year / year +300% on average on one year2, Uptake not yet materialized in Europe 1 Source : Wohlers report 2020 14 2 Average share price growth of major US 3D Printing players since 16/03/2020
STRONG STRATEGIC POSITION TO BENEFIT FROM SUPPORTING TRENDS A differentiating offer 1 Solutions on the whole value chain of 3D printing Software, Printers, Materials, Manufacturing 1st grade performance for industrial production 2 for mass customized applications Technologies offering unique precision & speed on the market R&D with Essilor for manufacturing lenses, Development of new partnerships 3 for new applications with significant potential R&D with a leading dental player for new products Opportunities in precision casting 15
GUIDANCE 2021 & FUTURE AMBITIONS: STRONG GROWTH IN 2021 & BEYOND 2021 Beyond Double-digit revenue growth & Strong development of all activities improving profitability starting in H1 2021 16
Q&A 17
You can also read